Comparison of hepatitis B surface antibody levels induced by the pentavalent DTwP-HB-Hib versus the hexavalent DTaP-HB-Hib-IPV vaccine, administered to infants at 2, 4, 6, and 18 months of age, following monovalent hepatitis B vaccination at birth
In Thailand, the hepatitis B (HB) vaccine is administered as a tetravalent vaccine (DTwP-HB) to all infants at 2, 4, and 6 months of age, following an initial vaccination with a monovalent HB vaccine at birth. As part of ongoing vaccine evaluation, we aimed to compare the hepatitis B immunogenicity...
Ausführliche Beschreibung
Autor*in: |
Posuwan, Nawarat [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2020 |
---|
Schlagwörter: |
---|
Umfang: |
9 |
---|
Übergeordnetes Werk: |
Enthalten in: Quantifying contributions of leaf area and longevity to leaf area duration under increased planting density and nitrogen input regimens during maize yield improvement - Li, Yaoyao ELSEVIER, 2022, Amsterdam |
---|---|
Übergeordnetes Werk: |
volume:38 ; year:2020 ; number:7 ; day:11 ; month:02 ; pages:1643-1651 ; extent:9 |
Links: |
---|
DOI / URN: |
10.1016/j.vaccine.2019.12.065 |
---|
Katalog-ID: |
ELV049282050 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV049282050 | ||
003 | DE-627 | ||
005 | 20230624153231.0 | ||
007 | cr uuu---uuuuu | ||
008 | 200518s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.vaccine.2019.12.065 |2 doi | |
028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000904.pica |
035 | |a (DE-627)ELV049282050 | ||
035 | |a (ELSEVIER)S0264-410X(19)31729-3 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 630 |a 640 |q VZ |
084 | |a 48.00 |2 bkl | ||
100 | 1 | |a Posuwan, Nawarat |e verfasserin |4 aut | |
245 | 1 | 0 | |a Comparison of hepatitis B surface antibody levels induced by the pentavalent DTwP-HB-Hib versus the hexavalent DTaP-HB-Hib-IPV vaccine, administered to infants at 2, 4, 6, and 18 months of age, following monovalent hepatitis B vaccination at birth |
264 | 1 | |c 2020 | |
300 | |a 9 | ||
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a In Thailand, the hepatitis B (HB) vaccine is administered as a tetravalent vaccine (DTwP-HB) to all infants at 2, 4, and 6 months of age, following an initial vaccination with a monovalent HB vaccine at birth. As part of ongoing vaccine evaluation, we aimed to compare the hepatitis B immunogenicity profiles of children who had received either the pentavalent (DTwP-HB-Hib) or the hexavalent (DTaP-HB-Hib-IPV) vaccine. | ||
650 | 7 | |a Pentavalent |2 Elsevier | |
650 | 7 | |a Immunogenicity |2 Elsevier | |
650 | 7 | |a Hexavalent |2 Elsevier | |
650 | 7 | |a Vaccine |2 Elsevier | |
650 | 7 | |a Hepatitis B |2 Elsevier | |
700 | 1 | |a Wanlapakorn, Nasamon |4 oth | |
700 | 1 | |a Vongpunsawad, Sompong |4 oth | |
700 | 1 | |a Sintusek, Palittiya |4 oth | |
700 | 1 | |a Leuridan, Elke |4 oth | |
700 | 1 | |a Van Damme, Pierre |4 oth | |
700 | 1 | |a Poovorawan, Yong |4 oth | |
773 | 0 | 8 | |i Enthalten in |n Elsevier |a Li, Yaoyao ELSEVIER |t Quantifying contributions of leaf area and longevity to leaf area duration under increased planting density and nitrogen input regimens during maize yield improvement |d 2022 |g Amsterdam |w (DE-627)ELV007884451 |
773 | 1 | 8 | |g volume:38 |g year:2020 |g number:7 |g day:11 |g month:02 |g pages:1643-1651 |g extent:9 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.vaccine.2019.12.065 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
912 | |a SSG-OPC-FOR | ||
936 | b | k | |a 48.00 |j Land- und Forstwirtschaft: Allgemeines |q VZ |
951 | |a AR | ||
952 | |d 38 |j 2020 |e 7 |b 11 |c 0211 |h 1643-1651 |g 9 |
author_variant |
n p np |
---|---|
matchkey_str |
posuwannawaratwanlapakornnasamonvongpuns:2020----:oprsnfeaiibufcatbdlvlidcdyhpnaaettpbivruteeaaettpbiivacnamnseetifnst4ad8ots |
hierarchy_sort_str |
2020 |
bklnumber |
48.00 |
publishDate |
2020 |
allfields |
10.1016/j.vaccine.2019.12.065 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000904.pica (DE-627)ELV049282050 (ELSEVIER)S0264-410X(19)31729-3 DE-627 ger DE-627 rakwb eng 630 640 VZ 48.00 bkl Posuwan, Nawarat verfasserin aut Comparison of hepatitis B surface antibody levels induced by the pentavalent DTwP-HB-Hib versus the hexavalent DTaP-HB-Hib-IPV vaccine, administered to infants at 2, 4, 6, and 18 months of age, following monovalent hepatitis B vaccination at birth 2020 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier In Thailand, the hepatitis B (HB) vaccine is administered as a tetravalent vaccine (DTwP-HB) to all infants at 2, 4, and 6 months of age, following an initial vaccination with a monovalent HB vaccine at birth. As part of ongoing vaccine evaluation, we aimed to compare the hepatitis B immunogenicity profiles of children who had received either the pentavalent (DTwP-HB-Hib) or the hexavalent (DTaP-HB-Hib-IPV) vaccine. Pentavalent Elsevier Immunogenicity Elsevier Hexavalent Elsevier Vaccine Elsevier Hepatitis B Elsevier Wanlapakorn, Nasamon oth Vongpunsawad, Sompong oth Sintusek, Palittiya oth Leuridan, Elke oth Van Damme, Pierre oth Poovorawan, Yong oth Enthalten in Elsevier Li, Yaoyao ELSEVIER Quantifying contributions of leaf area and longevity to leaf area duration under increased planting density and nitrogen input regimens during maize yield improvement 2022 Amsterdam (DE-627)ELV007884451 volume:38 year:2020 number:7 day:11 month:02 pages:1643-1651 extent:9 https://doi.org/10.1016/j.vaccine.2019.12.065 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-FOR 48.00 Land- und Forstwirtschaft: Allgemeines VZ AR 38 2020 7 11 0211 1643-1651 9 |
spelling |
10.1016/j.vaccine.2019.12.065 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000904.pica (DE-627)ELV049282050 (ELSEVIER)S0264-410X(19)31729-3 DE-627 ger DE-627 rakwb eng 630 640 VZ 48.00 bkl Posuwan, Nawarat verfasserin aut Comparison of hepatitis B surface antibody levels induced by the pentavalent DTwP-HB-Hib versus the hexavalent DTaP-HB-Hib-IPV vaccine, administered to infants at 2, 4, 6, and 18 months of age, following monovalent hepatitis B vaccination at birth 2020 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier In Thailand, the hepatitis B (HB) vaccine is administered as a tetravalent vaccine (DTwP-HB) to all infants at 2, 4, and 6 months of age, following an initial vaccination with a monovalent HB vaccine at birth. As part of ongoing vaccine evaluation, we aimed to compare the hepatitis B immunogenicity profiles of children who had received either the pentavalent (DTwP-HB-Hib) or the hexavalent (DTaP-HB-Hib-IPV) vaccine. Pentavalent Elsevier Immunogenicity Elsevier Hexavalent Elsevier Vaccine Elsevier Hepatitis B Elsevier Wanlapakorn, Nasamon oth Vongpunsawad, Sompong oth Sintusek, Palittiya oth Leuridan, Elke oth Van Damme, Pierre oth Poovorawan, Yong oth Enthalten in Elsevier Li, Yaoyao ELSEVIER Quantifying contributions of leaf area and longevity to leaf area duration under increased planting density and nitrogen input regimens during maize yield improvement 2022 Amsterdam (DE-627)ELV007884451 volume:38 year:2020 number:7 day:11 month:02 pages:1643-1651 extent:9 https://doi.org/10.1016/j.vaccine.2019.12.065 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-FOR 48.00 Land- und Forstwirtschaft: Allgemeines VZ AR 38 2020 7 11 0211 1643-1651 9 |
allfields_unstemmed |
10.1016/j.vaccine.2019.12.065 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000904.pica (DE-627)ELV049282050 (ELSEVIER)S0264-410X(19)31729-3 DE-627 ger DE-627 rakwb eng 630 640 VZ 48.00 bkl Posuwan, Nawarat verfasserin aut Comparison of hepatitis B surface antibody levels induced by the pentavalent DTwP-HB-Hib versus the hexavalent DTaP-HB-Hib-IPV vaccine, administered to infants at 2, 4, 6, and 18 months of age, following monovalent hepatitis B vaccination at birth 2020 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier In Thailand, the hepatitis B (HB) vaccine is administered as a tetravalent vaccine (DTwP-HB) to all infants at 2, 4, and 6 months of age, following an initial vaccination with a monovalent HB vaccine at birth. As part of ongoing vaccine evaluation, we aimed to compare the hepatitis B immunogenicity profiles of children who had received either the pentavalent (DTwP-HB-Hib) or the hexavalent (DTaP-HB-Hib-IPV) vaccine. Pentavalent Elsevier Immunogenicity Elsevier Hexavalent Elsevier Vaccine Elsevier Hepatitis B Elsevier Wanlapakorn, Nasamon oth Vongpunsawad, Sompong oth Sintusek, Palittiya oth Leuridan, Elke oth Van Damme, Pierre oth Poovorawan, Yong oth Enthalten in Elsevier Li, Yaoyao ELSEVIER Quantifying contributions of leaf area and longevity to leaf area duration under increased planting density and nitrogen input regimens during maize yield improvement 2022 Amsterdam (DE-627)ELV007884451 volume:38 year:2020 number:7 day:11 month:02 pages:1643-1651 extent:9 https://doi.org/10.1016/j.vaccine.2019.12.065 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-FOR 48.00 Land- und Forstwirtschaft: Allgemeines VZ AR 38 2020 7 11 0211 1643-1651 9 |
allfieldsGer |
10.1016/j.vaccine.2019.12.065 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000904.pica (DE-627)ELV049282050 (ELSEVIER)S0264-410X(19)31729-3 DE-627 ger DE-627 rakwb eng 630 640 VZ 48.00 bkl Posuwan, Nawarat verfasserin aut Comparison of hepatitis B surface antibody levels induced by the pentavalent DTwP-HB-Hib versus the hexavalent DTaP-HB-Hib-IPV vaccine, administered to infants at 2, 4, 6, and 18 months of age, following monovalent hepatitis B vaccination at birth 2020 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier In Thailand, the hepatitis B (HB) vaccine is administered as a tetravalent vaccine (DTwP-HB) to all infants at 2, 4, and 6 months of age, following an initial vaccination with a monovalent HB vaccine at birth. As part of ongoing vaccine evaluation, we aimed to compare the hepatitis B immunogenicity profiles of children who had received either the pentavalent (DTwP-HB-Hib) or the hexavalent (DTaP-HB-Hib-IPV) vaccine. Pentavalent Elsevier Immunogenicity Elsevier Hexavalent Elsevier Vaccine Elsevier Hepatitis B Elsevier Wanlapakorn, Nasamon oth Vongpunsawad, Sompong oth Sintusek, Palittiya oth Leuridan, Elke oth Van Damme, Pierre oth Poovorawan, Yong oth Enthalten in Elsevier Li, Yaoyao ELSEVIER Quantifying contributions of leaf area and longevity to leaf area duration under increased planting density and nitrogen input regimens during maize yield improvement 2022 Amsterdam (DE-627)ELV007884451 volume:38 year:2020 number:7 day:11 month:02 pages:1643-1651 extent:9 https://doi.org/10.1016/j.vaccine.2019.12.065 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-FOR 48.00 Land- und Forstwirtschaft: Allgemeines VZ AR 38 2020 7 11 0211 1643-1651 9 |
allfieldsSound |
10.1016/j.vaccine.2019.12.065 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000904.pica (DE-627)ELV049282050 (ELSEVIER)S0264-410X(19)31729-3 DE-627 ger DE-627 rakwb eng 630 640 VZ 48.00 bkl Posuwan, Nawarat verfasserin aut Comparison of hepatitis B surface antibody levels induced by the pentavalent DTwP-HB-Hib versus the hexavalent DTaP-HB-Hib-IPV vaccine, administered to infants at 2, 4, 6, and 18 months of age, following monovalent hepatitis B vaccination at birth 2020 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier In Thailand, the hepatitis B (HB) vaccine is administered as a tetravalent vaccine (DTwP-HB) to all infants at 2, 4, and 6 months of age, following an initial vaccination with a monovalent HB vaccine at birth. As part of ongoing vaccine evaluation, we aimed to compare the hepatitis B immunogenicity profiles of children who had received either the pentavalent (DTwP-HB-Hib) or the hexavalent (DTaP-HB-Hib-IPV) vaccine. Pentavalent Elsevier Immunogenicity Elsevier Hexavalent Elsevier Vaccine Elsevier Hepatitis B Elsevier Wanlapakorn, Nasamon oth Vongpunsawad, Sompong oth Sintusek, Palittiya oth Leuridan, Elke oth Van Damme, Pierre oth Poovorawan, Yong oth Enthalten in Elsevier Li, Yaoyao ELSEVIER Quantifying contributions of leaf area and longevity to leaf area duration under increased planting density and nitrogen input regimens during maize yield improvement 2022 Amsterdam (DE-627)ELV007884451 volume:38 year:2020 number:7 day:11 month:02 pages:1643-1651 extent:9 https://doi.org/10.1016/j.vaccine.2019.12.065 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-FOR 48.00 Land- und Forstwirtschaft: Allgemeines VZ AR 38 2020 7 11 0211 1643-1651 9 |
language |
English |
source |
Enthalten in Quantifying contributions of leaf area and longevity to leaf area duration under increased planting density and nitrogen input regimens during maize yield improvement Amsterdam volume:38 year:2020 number:7 day:11 month:02 pages:1643-1651 extent:9 |
sourceStr |
Enthalten in Quantifying contributions of leaf area and longevity to leaf area duration under increased planting density and nitrogen input regimens during maize yield improvement Amsterdam volume:38 year:2020 number:7 day:11 month:02 pages:1643-1651 extent:9 |
format_phy_str_mv |
Article |
bklname |
Land- und Forstwirtschaft: Allgemeines |
institution |
findex.gbv.de |
topic_facet |
Pentavalent Immunogenicity Hexavalent Vaccine Hepatitis B |
dewey-raw |
630 |
isfreeaccess_bool |
false |
container_title |
Quantifying contributions of leaf area and longevity to leaf area duration under increased planting density and nitrogen input regimens during maize yield improvement |
authorswithroles_txt_mv |
Posuwan, Nawarat @@aut@@ Wanlapakorn, Nasamon @@oth@@ Vongpunsawad, Sompong @@oth@@ Sintusek, Palittiya @@oth@@ Leuridan, Elke @@oth@@ Van Damme, Pierre @@oth@@ Poovorawan, Yong @@oth@@ |
publishDateDaySort_date |
2020-01-11T00:00:00Z |
hierarchy_top_id |
ELV007884451 |
dewey-sort |
3630 |
id |
ELV049282050 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV049282050</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624153231.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">200518s2020 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.vaccine.2019.12.065</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000904.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV049282050</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0264-410X(19)31729-3</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">630</subfield><subfield code="a">640</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">48.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Posuwan, Nawarat</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Comparison of hepatitis B surface antibody levels induced by the pentavalent DTwP-HB-Hib versus the hexavalent DTaP-HB-Hib-IPV vaccine, administered to infants at 2, 4, 6, and 18 months of age, following monovalent hepatitis B vaccination at birth</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2020</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">In Thailand, the hepatitis B (HB) vaccine is administered as a tetravalent vaccine (DTwP-HB) to all infants at 2, 4, and 6 months of age, following an initial vaccination with a monovalent HB vaccine at birth. As part of ongoing vaccine evaluation, we aimed to compare the hepatitis B immunogenicity profiles of children who had received either the pentavalent (DTwP-HB-Hib) or the hexavalent (DTaP-HB-Hib-IPV) vaccine.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pentavalent</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Immunogenicity</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Hexavalent</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Vaccine</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Hepatitis B</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wanlapakorn, Nasamon</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Vongpunsawad, Sompong</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sintusek, Palittiya</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Leuridan, Elke</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Van Damme, Pierre</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Poovorawan, Yong</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Li, Yaoyao ELSEVIER</subfield><subfield code="t">Quantifying contributions of leaf area and longevity to leaf area duration under increased planting density and nitrogen input regimens during maize yield improvement</subfield><subfield code="d">2022</subfield><subfield code="g">Amsterdam</subfield><subfield code="w">(DE-627)ELV007884451</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:38</subfield><subfield code="g">year:2020</subfield><subfield code="g">number:7</subfield><subfield code="g">day:11</subfield><subfield code="g">month:02</subfield><subfield code="g">pages:1643-1651</subfield><subfield code="g">extent:9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.vaccine.2019.12.065</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-FOR</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">48.00</subfield><subfield code="j">Land- und Forstwirtschaft: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">38</subfield><subfield code="j">2020</subfield><subfield code="e">7</subfield><subfield code="b">11</subfield><subfield code="c">0211</subfield><subfield code="h">1643-1651</subfield><subfield code="g">9</subfield></datafield></record></collection>
|
author |
Posuwan, Nawarat |
spellingShingle |
Posuwan, Nawarat ddc 630 bkl 48.00 Elsevier Pentavalent Elsevier Immunogenicity Elsevier Hexavalent Elsevier Vaccine Elsevier Hepatitis B Comparison of hepatitis B surface antibody levels induced by the pentavalent DTwP-HB-Hib versus the hexavalent DTaP-HB-Hib-IPV vaccine, administered to infants at 2, 4, 6, and 18 months of age, following monovalent hepatitis B vaccination at birth |
authorStr |
Posuwan, Nawarat |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV007884451 |
format |
electronic Article |
dewey-ones |
630 - Agriculture & related technologies 640 - Home & family management |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
630 640 VZ 48.00 bkl Comparison of hepatitis B surface antibody levels induced by the pentavalent DTwP-HB-Hib versus the hexavalent DTaP-HB-Hib-IPV vaccine, administered to infants at 2, 4, 6, and 18 months of age, following monovalent hepatitis B vaccination at birth Pentavalent Elsevier Immunogenicity Elsevier Hexavalent Elsevier Vaccine Elsevier Hepatitis B Elsevier |
topic |
ddc 630 bkl 48.00 Elsevier Pentavalent Elsevier Immunogenicity Elsevier Hexavalent Elsevier Vaccine Elsevier Hepatitis B |
topic_unstemmed |
ddc 630 bkl 48.00 Elsevier Pentavalent Elsevier Immunogenicity Elsevier Hexavalent Elsevier Vaccine Elsevier Hepatitis B |
topic_browse |
ddc 630 bkl 48.00 Elsevier Pentavalent Elsevier Immunogenicity Elsevier Hexavalent Elsevier Vaccine Elsevier Hepatitis B |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
n w nw s v sv p s ps e l el d p v dp dpv y p yp |
hierarchy_parent_title |
Quantifying contributions of leaf area and longevity to leaf area duration under increased planting density and nitrogen input regimens during maize yield improvement |
hierarchy_parent_id |
ELV007884451 |
dewey-tens |
630 - Agriculture 640 - Home & family management |
hierarchy_top_title |
Quantifying contributions of leaf area and longevity to leaf area duration under increased planting density and nitrogen input regimens during maize yield improvement |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV007884451 |
title |
Comparison of hepatitis B surface antibody levels induced by the pentavalent DTwP-HB-Hib versus the hexavalent DTaP-HB-Hib-IPV vaccine, administered to infants at 2, 4, 6, and 18 months of age, following monovalent hepatitis B vaccination at birth |
ctrlnum |
(DE-627)ELV049282050 (ELSEVIER)S0264-410X(19)31729-3 |
title_full |
Comparison of hepatitis B surface antibody levels induced by the pentavalent DTwP-HB-Hib versus the hexavalent DTaP-HB-Hib-IPV vaccine, administered to infants at 2, 4, 6, and 18 months of age, following monovalent hepatitis B vaccination at birth |
author_sort |
Posuwan, Nawarat |
journal |
Quantifying contributions of leaf area and longevity to leaf area duration under increased planting density and nitrogen input regimens during maize yield improvement |
journalStr |
Quantifying contributions of leaf area and longevity to leaf area duration under increased planting density and nitrogen input regimens during maize yield improvement |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
600 - Technology |
recordtype |
marc |
publishDateSort |
2020 |
contenttype_str_mv |
zzz |
container_start_page |
1643 |
author_browse |
Posuwan, Nawarat |
container_volume |
38 |
physical |
9 |
class |
630 640 VZ 48.00 bkl |
format_se |
Elektronische Aufsätze |
author-letter |
Posuwan, Nawarat |
doi_str_mv |
10.1016/j.vaccine.2019.12.065 |
dewey-full |
630 640 |
title_sort |
comparison of hepatitis b surface antibody levels induced by the pentavalent dtwp-hb-hib versus the hexavalent dtap-hb-hib-ipv vaccine, administered to infants at 2, 4, 6, and 18 months of age, following monovalent hepatitis b vaccination at birth |
title_auth |
Comparison of hepatitis B surface antibody levels induced by the pentavalent DTwP-HB-Hib versus the hexavalent DTaP-HB-Hib-IPV vaccine, administered to infants at 2, 4, 6, and 18 months of age, following monovalent hepatitis B vaccination at birth |
abstract |
In Thailand, the hepatitis B (HB) vaccine is administered as a tetravalent vaccine (DTwP-HB) to all infants at 2, 4, and 6 months of age, following an initial vaccination with a monovalent HB vaccine at birth. As part of ongoing vaccine evaluation, we aimed to compare the hepatitis B immunogenicity profiles of children who had received either the pentavalent (DTwP-HB-Hib) or the hexavalent (DTaP-HB-Hib-IPV) vaccine. |
abstractGer |
In Thailand, the hepatitis B (HB) vaccine is administered as a tetravalent vaccine (DTwP-HB) to all infants at 2, 4, and 6 months of age, following an initial vaccination with a monovalent HB vaccine at birth. As part of ongoing vaccine evaluation, we aimed to compare the hepatitis B immunogenicity profiles of children who had received either the pentavalent (DTwP-HB-Hib) or the hexavalent (DTaP-HB-Hib-IPV) vaccine. |
abstract_unstemmed |
In Thailand, the hepatitis B (HB) vaccine is administered as a tetravalent vaccine (DTwP-HB) to all infants at 2, 4, and 6 months of age, following an initial vaccination with a monovalent HB vaccine at birth. As part of ongoing vaccine evaluation, we aimed to compare the hepatitis B immunogenicity profiles of children who had received either the pentavalent (DTwP-HB-Hib) or the hexavalent (DTaP-HB-Hib-IPV) vaccine. |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-FOR |
container_issue |
7 |
title_short |
Comparison of hepatitis B surface antibody levels induced by the pentavalent DTwP-HB-Hib versus the hexavalent DTaP-HB-Hib-IPV vaccine, administered to infants at 2, 4, 6, and 18 months of age, following monovalent hepatitis B vaccination at birth |
url |
https://doi.org/10.1016/j.vaccine.2019.12.065 |
remote_bool |
true |
author2 |
Wanlapakorn, Nasamon Vongpunsawad, Sompong Sintusek, Palittiya Leuridan, Elke Van Damme, Pierre Poovorawan, Yong |
author2Str |
Wanlapakorn, Nasamon Vongpunsawad, Sompong Sintusek, Palittiya Leuridan, Elke Van Damme, Pierre Poovorawan, Yong |
ppnlink |
ELV007884451 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth oth oth oth oth |
doi_str |
10.1016/j.vaccine.2019.12.065 |
up_date |
2024-07-06T21:08:28.057Z |
_version_ |
1803865406107025408 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV049282050</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624153231.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">200518s2020 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.vaccine.2019.12.065</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000904.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV049282050</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0264-410X(19)31729-3</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">630</subfield><subfield code="a">640</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">48.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Posuwan, Nawarat</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Comparison of hepatitis B surface antibody levels induced by the pentavalent DTwP-HB-Hib versus the hexavalent DTaP-HB-Hib-IPV vaccine, administered to infants at 2, 4, 6, and 18 months of age, following monovalent hepatitis B vaccination at birth</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2020</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">In Thailand, the hepatitis B (HB) vaccine is administered as a tetravalent vaccine (DTwP-HB) to all infants at 2, 4, and 6 months of age, following an initial vaccination with a monovalent HB vaccine at birth. As part of ongoing vaccine evaluation, we aimed to compare the hepatitis B immunogenicity profiles of children who had received either the pentavalent (DTwP-HB-Hib) or the hexavalent (DTaP-HB-Hib-IPV) vaccine.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pentavalent</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Immunogenicity</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Hexavalent</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Vaccine</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Hepatitis B</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wanlapakorn, Nasamon</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Vongpunsawad, Sompong</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sintusek, Palittiya</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Leuridan, Elke</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Van Damme, Pierre</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Poovorawan, Yong</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Li, Yaoyao ELSEVIER</subfield><subfield code="t">Quantifying contributions of leaf area and longevity to leaf area duration under increased planting density and nitrogen input regimens during maize yield improvement</subfield><subfield code="d">2022</subfield><subfield code="g">Amsterdam</subfield><subfield code="w">(DE-627)ELV007884451</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:38</subfield><subfield code="g">year:2020</subfield><subfield code="g">number:7</subfield><subfield code="g">day:11</subfield><subfield code="g">month:02</subfield><subfield code="g">pages:1643-1651</subfield><subfield code="g">extent:9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.vaccine.2019.12.065</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-FOR</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">48.00</subfield><subfield code="j">Land- und Forstwirtschaft: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">38</subfield><subfield code="j">2020</subfield><subfield code="e">7</subfield><subfield code="b">11</subfield><subfield code="c">0211</subfield><subfield code="h">1643-1651</subfield><subfield code="g">9</subfield></datafield></record></collection>
|
score |
7.3985195 |